Combined Ophthalmology and Rheumatology Evaluation in Systemic Autoimmune Diseases with Ocular Involvement: A Third Level Reference Center in Mexico

被引:2
作者
Baquero-Ospina, Pablo [1 ]
Paquentin-Jimenez, Rebeca [2 ]
Hubbe-Tena, Claudia [1 ]
Elena Concha-Del-Rio, Luz [1 ]
机构
[1] Assoc Evitar Ceguera Mexico, Inflammatory Eye Dis Clin, IAP, Mexico City, DF, Mexico
[2] Assoc Evitar Ceguera Mexico, IAP, Community Serv Inflammatory Eye Dis Clin, Mexico City, DF, Mexico
关键词
Autoimmune diseases; epidemiology; etiology; eye; rheumatic diseases; uveitis; SJOGRENS-SYNDROME; REFERRAL CENTER; UVEITIS; EPIDEMIOLOGY; SCLERITIS; MANIFESTATIONS; EYE; SPONDYLOARTHRITIS; CLASSIFICATION; NOMENCLATURE;
D O I
10.1080/09273948.2022.2079532
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim A cross-sectional descriptive study to determine the frequency of ocular manifestations associated with systemic autoimmune diseases in a third-level hospital in Mexico. Methods Records from 2014 to 2017 at the Inflammatory Eye Disease Clinic of the Asociacion Para Evitar la Cegueraen Mexico were examined by both an ophthalmologist and a rheumatologist on the same day. Diagnosis was achieved from initial ocular manifestations with later systemic assessment. Results Out of 311 medical records, 276 were included, 75% of the patients were female. Keratoconjunctivitis sicca was the most frequent ocular manifestation (33.3%), followed by anterior uveitis (29.5%), scleritis (23.2%), and peripheral ulcerative keratitis (7.2%). The leading autoimmune diseases were spondyloarthritis (29%), rheumatoid arthritis (28.6%), primary Sjogren's syndrome (10.5%) and granulomatosis with polyangiitis (9.1%). 41.3% of systemic disease diagnoses were made after an initial ocular manifestation. Conclusions Inflammatory eye manifestations can imply systemic autoimmune diseases. It is crucial to suspect and confirm this association and provide timely interdisciplinary management.
引用
收藏
页码:989 / 995
页数:7
相关论文
共 50 条
  • [1] Retinal vasculitis
    Abu El-Asrar, A
    Herbort, C
    Tabbara, K
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (06) : 415 - 433
  • [2] Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions
    Agarwal, Aniruddha
    Karkhur, Samendra
    Aggarwal, Kanika
    Invernizzi, Alessandro
    Singh, Ramandeep
    Dogra, Mangat R.
    Gupta, Vishali
    Gupta, Amod
    Do, Diana V.
    Nguyen, Quan D.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 (01) : 62 - 74
  • [3] Evaluation of patients with scleritis for systemic disease
    Akpek, EK
    Thorne, JE
    Qazi, FA
    Do, DV
    Jabs, DA
    [J]. OPHTHALMOLOGY, 2004, 111 (03) : 501 - 506
  • [4] Severity of episcleritis and systemic disease association
    Akpek, EK
    Uy, HS
    Christen, W
    Gurdal, C
    Foster, CS
    [J]. OPHTHALMOLOGY, 1999, 106 (04) : 729 - 731
  • [5] Epidemiology of uveitis in the mid-Atlantic United States
    Bajwa, Asima
    Osmanzada, Diba
    Osmanzada, Susan
    Khan, Irfan
    Patrie, Jim
    Xin, Wenjun
    Reddy, Ashvini K.
    [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 889 - 901
  • [6] Uveitis: Autoimmunity... and beyond
    Bertrand, Pierre-Jean
    Jamilloux, Yvan
    Ecochard, Rene
    Richard-Colmant, Gaelle
    Gerfaud-Valentin, Mathieu
    Guillaud, Martin
    Denis, Philippe
    Kodjikian, Laurent
    Seve, Pascal
    [J]. AUTOIMMUNITY REVIEWS, 2019, 18 (09)
  • [7] Sjogren syndrome
    Brito-Zeron, Pilar
    Baldini, Chiara
    Bootsma, Hendrika
    Bowman, Simon J.
    Jonsson, Roland
    Mariette, Xavier
    Sivils, Kathy
    Theander, Elke
    Tzioufas, Athanasios
    Ramos-Casals, Manuel
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2016, 2
  • [8] The causes of uveitis in a referral centre of Northern Italy
    Cimino L.
    Aldigeri R.
    Salvarani C.
    Zotti C.A.
    Boiardi L.
    Parmeggiani M.
    Casali B.
    Cappuccini L.
    [J]. International Ophthalmology, 2010, 30 (5) : 521 - 529
  • [9] Davidson A., 2014, AUTOIMMUN DIS, P19
  • [10] De la Mora A., 2016, J ARTHRITIS, V5, P1, DOI [10.4172/2167-7921.1000215, DOI 10.4172/2167-7921.1000215]